Displaying drugs 3076 - 3100 of 3139 in total
CHROMOPHORE (ASP-TYR-GLY)
Experimental
Atrasentan
Atrasentan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists. It is a novel, selective endothelin A receptor antagonist (SERA).
Investigational
BMS-275183
BMS-275183 has been used in trials studying the treatment of Tumors and Non-small Cell Lung Cancer.
Investigational
Razupenem
Razupenem has been used in trials studying the treatment of Skin Infections.
Investigational
Flurithromycin
Experimental
Cymarin
Experimental
Sphinxolide B
Experimental
Cannabinor
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Lanatoside C
Experimental
Uridine-Diphosphate-N-Acetylgalactosamine
Experimental
Uridine-Diphosphate-N-Acetylglucosamine
Experimental
D-Eritadenine
Experimental
Nelivaptan
Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.
Investigational
JTK-853
JTK-853 has been used in trials studying the treatment of Hepatitis C Virus Infection, Response to Therapy of.
Investigational
Paclitaxel docosahexaenoic acid
A combination of docosahexaenoic Acid (a natural fatty acid) and paclitaxel (an anticancer drug) being studied in the treatment of cancer. It is a type of mitotic inhibitor.
Investigational
Solithromycin
Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections.
Investigational
Tosyl-D-Proline
Experimental
Beloranib
Beloranib has been used in trials studying the treatment of Obesity, Over-weight, Type 2 Diabetes, Craniopharyngioma, and Hypothalamic Injury, among others.
Investigational
Curcumin sulfate
Experimental
Displaying drugs 3076 - 3100 of 3139 in total